Abstract 1491: ATM, CHEK2 and BLM mutant prostate cancers do not have high homologous recombination deficiency scores
Year: 2025
Type: conference-abstract
Source: Cancer Research
Institution: Institute of Oncology NN Petrov
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4409628473
